Patient-Provider Communications About Pharmacogenomic Results Increase Patient Recall of Medication Changes
暂无分享,去创建一个
Walter M. Stadler | David O. Meltzer | Mark J. Ratain | Rita Nanda | Keith Danahey | Brittany A. Borden | Sang Mee Lee | M. Ratain | D. Meltzer | D. Rubin | Tamar S. Polonsky | R. Nanda | P. O’Donnell | W. Stadler | J. Koyner | L. Patrick-Miller | A. Davis | D. Burnet | K. Danahey | M. Siegler | Y. Sacro | K. Lipstreuer | P. Galecki | Peter H. O’Donnell | David T. Rubin | Paige Galecki | Linda Patrick-Miller | Mark Siegler | Matthew J. Sorrentino | Yasmin Sacro | Andrew M. Davis | Kristen Lipstreuer | William R. Harper | Jay L. Koyner | Deborah L. Burnet | Robert T. Kavitt | M. Sorrentino | S. M. Lee | R. Kavitt | Yasmin Sacro | William Harper
[1] N. Arora,et al. Interacting with cancer patients: the significance of physicians' communication behavior. , 2003, Social science & medicine.
[2] Michael B Ward,et al. A critical analysis of barriers to the clinical implementation of pharmacogenomics , 2007, Therapeutics and clinical risk management.
[3] Brittany A. Borden,et al. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program , 2017, Clinical pharmacology and therapeutics.
[4] R. Altman,et al. Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing , 2017, Clinical pharmacology and therapeutics.
[5] R. Verbrugge,et al. Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey , 2012, Clinical pharmacology and therapeutics.
[6] EMR documentation of physician–patient communication following genomic counseling for actionable complex disease and pharmacogenomic results , 2017, Clinical genetics.
[7] Dan M. Roden,et al. Implementing genomic medicine in the clinic: the future is here , 2013, Genetics in Medicine.
[8] Mark J. Ratain,et al. Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system , 2017, J. Biomed. Informatics.
[9] H. Bosworth,et al. Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response. , 2014, Patient education and counseling.
[10] Cathy Schoen,et al. Physician–Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America’s Seniors , 2007, Journal of General Internal Medicine.
[11] Jon Emery,et al. Genetics education for primary-care providers , 2002, Nature Reviews Genetics.
[12] W. Kraus,et al. Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients , 2014, Journal of personalized medicine.
[13] Soma Das,et al. Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago “1,200 Patients Project” , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[14] M. Dimatteo,et al. The challenge of patient adherence , 2005, Therapeutics and clinical risk management.
[15] R. Kravitz,et al. Prescribing new medications: a taxonomy of physician-patient communication. , 2009, Communication & medicine.
[16] J. Peterson,et al. Clinician Perspectives on Using Pharmacogenomics in Clinical Practice. , 2015, Personalized medicine.
[17] W Burke,et al. Primary care physicians' knowledge of and experience with pharmacogenetic testing , 2012, Clinical genetics.
[18] J. Florez,et al. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey , 2009, Diabetologia.
[19] Nancy Longnecker,et al. Doctor-patient communication: a review. , 2010, The Ochsner journal.
[20] N J Cox,et al. The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics , 2012, Clinical pharmacology and therapeutics.
[21] Sylvie Dolbeault,et al. Doctor-patient communication and satisfaction with care in oncology , 2005, Current opinion in oncology.
[22] F. Frueh,et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial , 2013, The Pharmacogenomics Journal.
[23] R. Frankel,et al. Assessing Competence in Communication and Interpersonal Skills: The Kalamazoo II Report , 2004, Academic medicine : journal of the Association of American Medical Colleges.
[24] J. Herndon,et al. Continuing concerns, new challenges, and next steps in physician-patient communication. , 2002, The Journal of bone and joint surgery. American volume.
[25] M. Stewart. Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[26] S. Vahdat,et al. Patient Involvement in Health Care Decision Making: A Review , 2014, Iranian Red Crescent medical journal.
[27] Yee Ming Lee,et al. Disease–drug database for pharmacogenomic‐based prescribing , 2016, Clinical pharmacology and therapeutics.
[28] Shaurya Taran. An Examination of the Factors Contributing to Poor Communication Outside the Physician-Patient Sphere , 2011, McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students.
[29] A. Tomlinson,et al. Communication skills. , 1988, Nursing.
[30] S. Haga,et al. The potential impact of pharmacogenetic testing on medication adherence , 2013, The Pharmacogenomics Journal.
[31] R. Sharp,et al. Addressing gaps in physician education using personal genomic testing , 2011, Genetics in Medicine.
[32] M. Dimatteo,et al. Physician Communication and Patient Adherence to Treatment : A Meta-analysis , 2018 .
[33] W H Rogers,et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. , 1993, Archives of internal medicine.